Literature DB >> 30401966

Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis.

Bettina M Knoll1, Karen Seiter2, Adrienne Phillips3, Rosemary Soave4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30401966     DOI： 10.1038/s41409-018-0389-9

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases.

Authors:  Pierre Frange; Marianne Leruez-Ville
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation.

Authors:  Satoshi Kaito; Yujiro Nakajima; Konan Hara; Takashi Toya; Tetsuya Nishida; Naoyuki Uchida; Junichi Mukae; Takahiro Fukuda; Yukiyasu Ozawa; Masatsugu Tanaka; Kazuhiro Ikegame; Yuta Katayama; Takuro Kuriyama; Junya Kanda; Yoshiko Atsuta; Masao Ogata; Ayumi Taguchi; Kazuteru Ohashi
Journal:  Blood Adv       Date:  2020-03-24

3.  Antiviral Drugs Against Herpesviruses.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients.

Authors:  Cameron M Douglas; Richard Barnard; Daniel Holder; Randi Leavitt; Diane Levitan; Maureen Maguire; David Nickle; Valerie Teal; Hong Wan; Dirk C J G van Alewijk; Leen-Jan van Doorn; Sunwen Chou; Julie Strizki
Journal:  J Infect Dis       Date:  2020-03-16       Impact factor: 5.226

Review 5.  Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Authors:  Lauren Stern; Barbara Withers; Selmir Avdic; David Gottlieb; Allison Abendroth; Emily Blyth; Barry Slobedman
Journal:  Front Microbiol       Date:  2019-05-28       Impact factor: 5.640

6.  Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient.

Authors:  Susanne Jung; Manuela Michel; Thomas Stamminger; Detlef Michel
Journal:  BMC Infect Dis       Date:  2019-05-08       Impact factor: 3.090

Review 7.  Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy.

Authors:  Morgan Hakki
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 4.213

8.  Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.

Authors:  Ibrahim Aldoss; Corinna La Rosa; Lindsey R Baden; Jeffrey Longmate; Ella J Ariza-Heredia; Wasima N Rida; Chetan Raj Lingaraju; Qiao Zhou; Joy Martinez; Teodora Kaltcheva; Andy Dagis; Nicola Hardwick; Nicolas C Issa; Len Farol; Auayporn Nademanee; Monzr M Al Malki; Stephen Forman; Ryotaro Nakamura; Don J Diamond
Journal:  Ann Intern Med       Date:  2020-02-11       Impact factor: 51.598

9.  Emergence and Persistence of Letermovir-Resistant Cytomegalovirus in a Patient With Primary Immunodeficiency.

Authors:  Stephanie Popping; Virgil A S H Dalm; Nadine Lübke; Veronica di Cristanziano; Rolf Kaiser; Charles A B Boucher; Jeroen J A Van Kampen
Journal:  Open Forum Infect Dis       Date:  2019-08-23       Impact factor: 3.835
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.